Egypt - Hikma
WEBIn Egypt, we produce and commercialise medicines from our three manufacturing plants, which specialise in cephalosporins, general formulation, and oncology medicines. In addition, we commercialise the medicines of our pharmaceutical partners who rely on our expertise and knowledge of the market.
MENA locations - Hikma
WEBFind contact details for any of our offices and locations in the MENA. Name *. Email *. Telephone *. Company. Enquiry type *. Medical information and report a possible side effect. Message *. Send enquiry.
Hikma Pharmaceuticals - Wikipedia
WEBHikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978.
Hikma
WEBAug 8, 2024 · Hikma. Play video. What we do. For more than 45 years we’ve been creating high-quality medicines and making them accessible to the people who need them. Learn more about how we do this across North America, MENA …
The fruits of investing in Egypt - LinkedIn
WEBAug 5, 2021 · Hikma employees go to work every day with a passion for improving the lives of Egyptian patients. Our well-diversified product portfolio is testament to our ability to transform cutting edge...
Hikma agrees to acquire the Egyptian Company for …
WEBJan 10, 2013 · Hikma Egypt is currently the seventeenth largest pharmaceutical manufacturer in Egypt, with an estimated market share of 1.6%. Commenting on the transaction, Said Darwazah, CEO of Hikma said ...
Hikma Pharmaceuticals : Egypt launches Hikma Specialized division …
WEBJun 7, 2016 · Hikma Pharmaceuticals Egypt manufactures and markets generic and in licensed pharmaceutical products with a focus on higher value, differentiated products spanning a broad range of therapeutic categories, including CNS, anti-infectives, cardiovascular and oncological therapeutic areas.
Hikma expands in Egypt with EPCI acquisition - PMLiVE
WEBJan 10, 2013 · Jordan’s Hikma Pharmaceuticals has continued its strategy of growth by acquisition with a deal to buy Egyptian Company for Pharmaceuticals & Chemical Industries (EPCI) for around $22m.
Hikma acquisition lands 2 plants in Egypt - Fierce Pharma
WEBJan 10, 2013 · Hikma, the Middle East-based drugmaker that has had some plant problems in the U.S., has picked up manufacturing capacity as it solidifies its position in the Egyptian market.
Hikma Pharmaceuticals signs MoU for potential acquisition of GSK Egypt
WEBJan 26, 2021 · Hikma Pharmaceuticals PLC, a British multinational pharmaceutical company, is looking to acquire a majority stake in GlaxoSmithKline (GSK) Egypt.